AiCuris

AiCuris

Germany - Wuppertal
Biotechnology

Focus: Anti-Infectives

AiCuris is a life sciences company focused on Anti-Infectives.

Infectious Diseases
Funding Stage
PUBLIC
Open Jobs
6

Pipeline & Clinical Trials

Pritelivir
HSV
N/A
Clinical Trials (1)
NCT05844436Expanded Access Intermediate Size Treatment Protocol: Pritelivir for Immunocompromised Subjects with Treatment Resistant Herpes Simplex Virus Type 1 or 2
N/A
Study to Assess Management and Outcomes of Hospitalised Patients With Complicated UTI (RESCUING)
Urinary Tract Infections
N/A
Clinical Trials (1)
NCT02641015Study to Assess Management and Outcomes of Hospitalised Patients With Complicated UTI (RESCUING)
N/A
Pritelivir and moxifloxacin placebo
Healthy Subjects
Phase 1
Clinical Trials (1)
NCT05671029Thorough QT/QTc of Pritelivir in Healthy Subjects
Phase 1
Pritelivir
HSV Infection
Phase 1
Clinical Trials (1)
NCT05513625Potential Influence of Esomeprazole on the Pharmacokinetics of Pritelivir
Phase 1
Pritelivir 5% w/w ointment
Herpes Labialis
Phase 2
Clinical Trials (1)
NCT02871492Trial on Efficacy and Safety of Pritelivir Ointment for Treatment of Labial Herpes
Phase 2
Clinical Trials (1)
NCT01063829Safety and Efficacy Study of a New Antiviral Drug to Prevent Cytomegalovirus Reactivation in Bone Marrow Transplanted Patients
Phase 2
Phase 2
Clinical Trials (1)
NCT01658826Safety and Efficacy Comparator Trial of a New Drug Against Genital Herpes
Phase 2
AIC316
HSV-2
Phase 2
Clinical Trials (1)
NCT01047540Safety and Efficacy Study for a New Antiviral Drug to Treat Genital Herpes Type 2
Phase 2
Pritelivir
HSV Infection
Phase 3
Clinical Trials (1)
NCT03073967Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects
Phase 3

Open Jobs (6)

Interview Prep Quick Facts
Portfolio: 9 clinical trials
Open Roles: 6 active jobs

Hiring Trend

Stable
6
Open Roles
+0
Added
-0
Filled/Removed

Based on last 4 crawl cycles